Donate online today. £10 provides 1 hour of in-depth support

meningitis & septicaemia can kill in hours!

People who are faced with meningitis and septicaemia have to act fast to help save a life.

Meningitis charity hopeful life saving vaccine will be introduced in Ireland

Meningitis charity hopeful life saving vaccine will be introduced in Ireland

02 April 2014

Campaigning charity Meningitis Research Foundation Ireland welcomes the news that the National Immunisation Advisory Committee (NIAC) is making a vaccine for meningococcal disease group B (MenB) a priority issue for careful consideration, following a recommendation to introduce the life saving vaccine in the UK.

NIAC’s statement follows news that its UK equivalent, the Joint Committee on Vaccination and Immunisation has recommended the vaccine for infants in three doses ages 2, 4 and 12 months. NIAC says it discussed introducing MenB into its primary immunisation programme at its meeting on 24 March and is seeking more information before making its recommendation.

Meningitis Research Foundation Manager Diane McConnell said: “MenB kills and disables more children in Ireland than any other infectious disease. That’s why this charity and our supporters have campaigned so hard for this vaccine. We applaud the decision taken by the JCVI, which means children in Northern Ireland will be protected from this deadly disease, and are hopeful that NIAC will also recognise the importance of this vaccine and introduce it here too.”

The MenB vaccine under consideration by NIAC is called Bexsero® and is produced by Novartis Vaccines. It was licensed by the European Union in January 2013.


Lewis Charles
Meningococcal disease
Meningococcal disease at 6

Holding your child, not knowing whether they will wake up or not.

More stories
News

Search the news: